Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BriaCell Therapeutics Corp. logo — Developing Novel Therapies to Destroy Cancer

BriaCell Therapeutics Corp.

Developing Novel Therapies to Destroy Cancer

Founded 2004 United States Philadelphia, United States 20 employees Post Ipo Equity Total: $36.20M Biotechnology, Health Care +2

General Information

Company Name BriaCell Therapeutics Corp.
Founded Year 2004
Location United States Philadelphia, United States +2
Employees 20
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Post Ipo Equity
Social

Get notified when BriaCell Therapeutics Corp. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer. The company achieved positive proof-of-concept in a Phase I/IIa clinical trial for Bria-IMT™ in patients with advanced breast cancer. Currently, it is conducting a Phase I/IIa clinical trial of Bria-IMT™ in combination with a PD-1 inhibitor, retifanlimab provided by Incyte under a collaboration agreement. Additionally, BriaCell is developing Bria-OTS™, the first “off-the-shelf” personalized immunotherapy for advanced breast cancer. Established in 2004, the company operates in the biotechnology, health care, and pharmaceutical industries and is headquartered in the United States. Recently, the company secured a $5.00 million post-IPO equity investment on 15 May 2024. The investors involved in this investment round are not disclosed. For additional information on BriaCell, please visit their website: briacell.com.

Taxonomy: BriaCell Therapeutics Corp, Immunotherapy, Cancer Research, Oncology, Clinical Trials, Personalized Medicine, PD-1 Inhibitor, Immunotherapy Development, Cancer Immunotherapy, Breast Cancer Treatment, Targeted Therapies, Innovative Biotech, Therapeutic Innovations

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 15 May 2024
Post-IPO Equity •••••• 1
Investor
15 May 2023
Post-IPO Equity •••••• - 03 Jun 2021

BriaCell Therapeutics Corp. Alternatives & Competitors

BriaCell Therapeutics Corp. vs
Ohana Vaccines, LLC
Ohana Vaccines, LLC

A company devoted to developing and testing therapeutic cancer vaccines, currently for prostate canc...

0-1 employees
Biotechnology, Health Care
BriaCell Therapeutics Corp. vs
Immunowake, Inc.
Immunowake, Inc. United States

Immunowake Inc. is a private, pre-clinical stage biotechnology company focused on cancer drug discov...

Series A
2 employees
Biotechnology
BriaCell Therapeutics Corp. vs
Sustainable Cell Therapeutics
Sustainable Cell Therapeutics

Pioneering cancer immunotherapy with a focus on patient rehabilitation and treatment of resilient an...

Seed
Biotechnology, Health Care

FAQ About BriaCell Therapeutics Corp.

Developing Novel Therapies to Destroy Cancer
BriaCell Therapeutics Corp. was founded in 2004.
BriaCell Therapeutics Corp. is headquartered in Philadelphia, United States.
BriaCell Therapeutics Corp. operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical.
BriaCell Therapeutics Corp. has approximately 20 employees.
BriaCell Therapeutics Corp. has completed 3 funding rounds, raising a total of $36.20M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to BriaCell Therapeutics Corp. include Ohana Vaccines, LLC, Immunowake, Inc., Sustainable Cell Therapeutics, Providence Health & Services, Prokarium. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BriaCell Therapeutics Corp. and Ohana Vaccines, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BriaCell Therapeutics Corp. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes